Synthesis and pharmacological properties of azido derivatives of 1,5-benzothiazepine Ca antagonist.
- 1 January 1990
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 38 (2) , 407-410
- https://doi.org/10.1248/cpb.38.407
Abstract
Sine azido dervatives of 1, 5-benzothiazepine Ca antagonist available for photoaffinity labeling are required for further studies of voltage-sensitive Ca channels, we synthesized 3-(p-azidobenzoyloxydeacetyl)- and 3-(4-azidobutyryloxydeacetyl)-diltiazem, and studied their pharmacological properties. Both azido compounds showed similar relaxing actions to diltiazem in K+ -depolarized dog arteries. They also showed a similar increasing action to diltiazem, but less potent, on the coronary and vertebral blood flow in the anesthetized dog. Moreover, their negative inotropic effects in the guinea pig papillary muscle were similar to or slightly more potent than that of diltiazem under physiological conditions, but were less potent when studied in K+ depolarizing solution. A radioligand binding study in rat skeletal muscle microsomes revealed that the azido derivatives had similar properties to diltiazem, but the nonspecific binding of 3-(p-azidobenzoyloxydeacetyl)-diltiazem was too high to allow estimation of its KD and Bmax values. In conclusion, we synthesized azido derivatives of diltiazem which were considered to share a common binding site on the voltage-dependent Ca channel with diltiazem in skeletal muscle microsomes and in vascular smooth muscle.Keywords
This publication has 6 references indexed in Scilit:
- Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations.Journal of Biological Chemistry, 1987
- The 165‐KDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channelEuropean Journal of Biochemistry, 1987
- THE RELATIONSHIP BETWEEN THE BINDING-SITE OF [H-3] D-CIS-DILTIAZEM AND THAT OF OTHER NONDIHYDROPYRIDINE CALCIUM ENTRY BLOCKERS IN CARDIAC SARCOLEMMA1987
- Receptor pharmacology of calcium entry blocking agentsThe American Journal of Cardiology, 1987
- Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.Journal of Biological Chemistry, 1986
- Diltiazem enhancement of [3H]nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomesBiochemical and Biophysical Research Communications, 1982